steroids in late ards类固醇ards年末.pdf

Available online at /content/11/4/310 Evidence-Based Medicine Journal Club EBM Journal Club Section Editor: Eric B. Milbrandt, MD, MPH Journal club critique Steroids in late ARDS? 1 2 3 Non Waja naponsan, Michael C. Reade, and Eric B. Milbrandt 1 Clinical Fellow, Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA 2 Visiting Instructor, Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA 3 Assistant Professor, Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA Published online: 20th July 2007 Critical Care 2007, 11: 310 (DOI 10.1186/cc5954) This article is online at /content/11/4/310 © 2007 BioMed Central Ltd Expanded Abstract number of ventilator-free days and organ-failure-free days, Citation biochemical markers of inflammation and fibroproliferation, and infectious complications. At 60 days, the hospital Steinberg KP, Hudson LD, Goodman RB, Hough CL, mortality rate was 28.6 percent in the placebo group (95 Lanken PN, Hyzy R, Thompson BT, Ancukiewicz M: percent confidence interval, 20.3 to 38.6 percent) and 29.2 Efficacy and safety of corticosteroids for persistent acute percent in the methylprednisolone group (95 percent respiratory distress syndrome. N Engl J M